A novel azaindole-2-ones inhibitors and antitumor activity fgfr1

The present invention provides novel azaindole having antitumor 2-ones of non-ATP competitive inhibitor of FGFR1. Further, the present invention also provides pharmaceutical compositions containing these compounds and the use of other anti-tumor.